16 Nov 2021  | Lenias Hwenda | Let's Talk about Health in Africa | Titans of Industry  | Oramed´s oral insulin and oral Covid vaccine are powerful innovations that could transform access dynamics in Africa  | Nadav Kidron, President & CEO Oramed Pharmaceuticals

Oramed was recently given approval from SAHPRA to initiate a phase 1 clinical trials for insulin. This vaccine is oral and does not require injection which simplifies logistics, it does not need to be given by a health professional and it does not require additional medical consumables like needs and syringes, all of which reduces its cost significantly. The President and CEO of Oramed pharmaceuticals, Nadav Kidron spoke to Lenias Hwenda about what this vaccines could mean on the African continent and his ambitions for the African continent.